Ofcom investigating Today programme over whether report on Bob Marley-branded cannabis 'glamorised' drugs
The regulator is looking into whether the item breached its broadcasting code
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.BBC Radio 4’s Today programme is being investigated by Ofcom over whether it “glamorised” drug use in a report about Bob-Marley-branded cannabis.
The broadcasting regulator is looking into whether the item “condoned, encouraged or glamorised the use of illegal substances”.
A range of cannabis products endorsed by the reggae musician were launched earlier this year after his family struck a deal with a US private equity firm to create a global “Marley Natural” marijuana brand.
During the Today show in question, which was aired on 19 November, business presenter Simon Jack spoke to the chief executive of the Seattle-based firm Privateer Holdings, which is behind the venture.
The products will go on sale next year in countries and jurisdictions where they are legal, and will include Jamaican cannabis strains, cannabis- and hemp-infused creams and lip balms as well as accessories inspired by Marley.
Ofcom announced today it was looking into whether the report breached its broadcasting code.
The BBC has responded to Ofcom and conceded that it could have done more to reflect the social impact of the drug.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments